Cargando…
Discovery of a Dual SENP1 and SENP2 Inhibitor
SUMOylation is a reversible post–translational modification (PTM) involving covalent attachment of small ubiquitin-related modifier (SUMO) proteins to substrate proteins. Dysregulation of SUMOylation and deSUMOylation results in cellular malfunction and is linked to various diseases, such as cancer....
Autores principales: | Brand, Michael, Bommeli, Elias Benjamin, Rütimann, Marc, Lindenmann, Urs, Riedl, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602571/ https://www.ncbi.nlm.nih.gov/pubmed/36292935 http://dx.doi.org/10.3390/ijms232012085 |
Ejemplares similares
-
SENP1 and SENP2 regulate SUMOylation of amyloid precursor protein
por: Maruyama, Takuma, et al.
Publicado: (2018) -
SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis
por: Cubeñas-Potts, Caelin, et al.
Publicado: (2013) -
Genetic Polymorphism of SUMO-Specific Cysteine Proteases − SENP1 and SENP2 in Breast Cancer
por: Mirecka, Alicja, et al.
Publicado: (2016) -
Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2
por: Chow, Kin-Hoe, et al.
Publicado: (2012) -
Lessons on Life from SENP2
por: Sedwick, Caitlin
Publicado: (2008)